Ovarian Cancer Research Grant Sonesavanh Shares Her Experiences
Sonesavanh Larnkham, a PhD candidate in the Pitman Lab Group at Te Herenga Waka Victoria University of Wellington, was awarded the Ovarian Cancer Foundation New Zealand’s inaugural International Travel Grant in 2024. This grant enabled Sonesavanh to visit a world-renowned ovarian cancer research facility at the University of Edinburgh, Scotland to learn from reputable ovarian […]
Annual Report 2024
We’re delighted to present our Annual Report, covering the period 1 April 2023 to 31 March 2024. It’s been incredible to reflect on the past year and all of the progress we have made together. This report highlights some remarkable achievements. We’ve committed to a long-term growth strategy, including changing our name to the Ovarian […]
Introducing Our New Funded Counselling Programme
We are thrilled to announce the launch of our pilot-funded counselling programme, designed to support women through the emotional and mental challenges of an ovarian cancer diagnosis. We understand how overwhelming it can be to face ovarian cancer, with unexpected obstacles and difficult decisions arising throughout the journey. This service is available to any woman […]
Update on Funding Application for Bevacizumab in Ovarian Cancer
The Ovarian Cancer Foundation New Zealand (OCFNZ) is incredibly pleased to hear that bevacizumab will likely be funded for women with newly diagnosed ovarian cancer in the near future. In September, Pharmac made a Request For Tender to suppliers, which is an important step towards funding in New Zealand. While the funding outcome is not […]
Report Progress & Meetings With Health Leaders
An advocacy update from our founder Jane Ludemann Over the past few years, we have worked hard to effect positive change for our ovarian cancer community, advocating for improvements in ovarian cancer care. I am pleased with the progress we are seeing and would like to share some of the steps being taken. A summary […]
Ovarian Cancer Can Affect Anyone: World Ovarian Cancer Day 2024
Wednesday 8 May is World Ovarian Cancer Day, an important day to shine a light on New Zealand’s least survivable gynaecological cancer. With one woman diagnosed every 29 hours, and a five-year survival rate of just 36% it’s crucial that New Zealanders learn the symptoms of ovarian cancer, and support the Ovarian Cancer Foundation’s efforts […]
Webinar Series
We are committed to helping women access the information and resources they need throughout their ovarian cancer diagnosis. To facilitate this, we’re launching a new webinar series led by professionals, covering a range of topics to inform and empower women living with ovarian cancer. Our webinar series has been developed with feedback from women living […]
PHARMAC announcement on niraparib funding
Today, PHARMAC has announced that from 1 May, 2024, they will be funding niraparib, a PARP inhibitor, for first-line and second line maintenance treatment of advanced, high-grade serous, platinum sensitive ovarian, fallopian tube or primary peritoneal cancer, subject to eligibility criteria. The Ovarian Cancer Foundation was pleased to see that niraparib would be funded for […]
We’re funding rehabilitation sessions
Treatment for ovarian cancer can be tough, both mentally and physically, and women can experience side effects and other physical changes. Specialised cancer rehabilitation can significantly improve a woman’s functional ability and quality of life – but rehabilitation is expensive, and we discovered that women with ovarian cancer trying to access support through PINC & […]
Overseas Travel Grant – Applications Open
The Ovarian Cancer Foundation New Zealand (OCFNZ) is proud to launch our first overseas travel grant – of up to $10,000 – to allow an early career researcher to gain experience in an international ovarian cancer research laboratory. OCFNZ will fund a candidate to visit one of four ovarian cancer research laboratories, preselected by OCFNZ, […]